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Marfan’s syndrome is an autosomal dominant disorder
of connective tissue that is characterised by skeletal,
ocular, and cardiovascular manifestasions. It is estimated
to have prevalence of 1:20.000 people, and at least 25
percent of the cases in the absence of a family history.
The syndrome shows full penetrance, but there is
considerable clinic variability both between and within
families (1). The manifestations relating to the skeletion
include tall stature, long and thin arms, and legs,
aracnhnodactyly (spidery fingers), scoliosis and kyfosis.
The ocular manifestations include upward subluxation of
the lenses, myopia and retinal detachment. The most lifethreatining complications are those of cardiovascular
system with dilatation with or without dissecting
aneurysm, of the ascending aorta, and less commonly
thoracic, abdominal aorta, or pulmonary artery. Mitral
valve prolapse is also very common. Without treatment
the cardiovascular complications, particularly dissection of
the assending aorta is the leading cause of premature
deaths (2-4).

Physical examination revealed a height of 169 cm
(over the 97th percentile for age), a body weight of 37 kg
(between the 10-25th percentile for age), an arm span of
176 cm (arm span-height>7 cm) and a ratio of upper
segment to lower segment of 0.85. Bone age was
determined as 13 years. Her mother’s height was
measured as 155 cm and father’s height as 192 cm. Her
target height, estimated from parental height, was
calculated as 167 cm. Table 1 shows the clinical
characteristics of our patient and her father related to
Marfan syndrome Figure 1 despicts the general
appearence of the patient, Figure 2 arachnodactyly, and
Figure 3 the joint hyperextention. Sexual maturation was
at stage II-III, according to Tanner.

Ectopia lentis

-

-

In this paper, we report a case of Marfan syndrome
with aortic root dilatation, mitral valve prolapsus, and
family history.

Myopia

+

+

Archnodactyly

+

+

Pectus escavatum

+

+

A thirteen-years-old girl was referred to our
outpatient clinic for investigation of tall stature. She had
diagnosed as having severe myopia, especially on the left
eye, during the eye examination. She had exercise
intolerance. Her mental development was normal. She
was the 3rd child of the nonconsanguinous marriage.
Other members of the family except for the father were
normal. It was learned that the father has had similar
features.

Loose joints

+

+

Table 1.

Clinical features of our patients.

Features

Our patient

Our patient’s father

Scoliosis

-

-

Height>95% for age

+

+

Aortic root dilatation

+

-

Mitral valve prolapse

+

+

Aortic regurgitasyon

-

-

Aortic dissection

-

-

Mental retardation

-

-
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Figure 3. Loose joint

The basic deffect in Marfan syndrome has recently
been traced to a deffective fibrillin gene mapped to
chromosome 15 (15 q21.1). Fibrillin is a connective
tissue protein found in microfibrils, as a constituent of a
elastic tissue and abundant in tissues affected in Marfan
syndrome, including the aorta, suspensory ligament of
the lens and the periosteum (5).

Figure 1. General apperance of the patient

Figure 2. Arachnodacthyly

Biochemical and hormonal evaluation was in normal
limits. Blood and urine amino acids were normal.
Echocardiograpy revealed aortic root dilatation and mitral
valve prolapsus without aortic and mitral regurgitation.
Also, mitral valve prolapsus was determined at father’s
echocardiographic examination. Patient’s karyotype was
46-XX.
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The diagnosis of Marfan syndrome is based on
following four major criteria: (a) a positive family history,
(b) involvement of skeletal, (c) the ocular and (d) the
cardiovascular systems. In the presence of two of these
four criteria, the diagnosis of Marfan syndrome can be
made (1). Our patient had all four major diagnostic
criteria.
Differential diagnosis should be made from Beals
syndrome (congenital, contractural arachnodactyly) and
homocystinuria, because of the similarities clinical
manifestations. Patients with Beal’s syndrome have
skelatal features, similar to those of Marfan syndrome
with long, slender limbs (dolichostenomelia) with
arachnodactyly. However, in Beals syndrome, there are
joint contractures rather than looseness of the joints, and
the eye and heart are not affected. Also in this syndrome,
there are camptodacyly of the fingers and folded helixes
of the ears. Homocystinuria should be considered in any
patient with Marfan like features (dolichostenomelia,
arachnodactyly, tall stature) osteoporosis, mental
retardation, and history of thromboembolic phenomen.
The subluxation of the lens downward, contary to
upward dislocation in Marfan syndrome, is the most
consistent finding of homocystinuria. Some patient may
have no discernible clinical manifestations, except for tall
stature. In this situitation, serum and urine amino acid
concentrations should be determined for differentiation
of homocystinuria (1, 5).
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Although several aproaches may reduce the morbidity
of Marfan syndrome, there is no specific tretment. Early
recognition and correction of a refractive error prevent
the amblyopia that often limits vision. Prevention and
correction of scliosis ad repair of the pectus deformity
may be very helpful. When significant aortic regurgitation
is noted, aortic valve prothesis may be utilised.
Progressive aortic dilatation may be managed by graft

placement. Attempts have been made to limit progression
of aortic dilatation by administering propranolol or some
other beta adrenergic agents (4, 6).
Life expectancy f patients with Marfan syndrome is
abot half that in general population. Half of the affected
males are dead by age 40-45, and half of affected females
die by age 50-55. In over 95% of patients death is due
to cardiovascular complications (6).
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